相关实验视频

Updated: Jun 24, 2025

An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis

An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis

Published on: September 12, 2019

肝细胞癌的免疫疗法:扩大获得肝移植的下一个进化

Michael Li¹, Sherrie Bhoori², Neil Mehta¹

¹Division of Gastroenterology and Hepatology, University of California, San Francisco, San Francisco CA, USA.

Journal of hepatology

|June 7, 2024

概括

免疫疗法正在改变肝细胞癌 (HCC) 治疗. 本综述探讨了它在肝移植前的潜在作用,以改善结果,同时考虑相关的免疫风险.

科学领域:

肝胆道手术肝胆道手术
移植手术移植手术
医学瘤学医学瘤学

背景情况:

免疫疗法已经显著推进了肝细胞癌 (HCC) 治疗,特别是在晚期.
最近的试验显示,免疫疗法与手术或局部区域疗法相结合,在早期至中期HCC中产生积极的结果.
免疫疗法的扩大应用引发了关于其在等待肝移植的患者中使用的问题.

研究的目的:

审查免疫疗法在肝移植前的HCC.肝移植前的免疫疗法的作用.
讨论潜在的好处,如改善降级和瘤控制.
在这个患者群体中探索免疫学风险,包括毒性和排斥.

主要方法:

审查当前文献和临床试验数据的免疫疗法对HCC.
分析支持组合免疫疗法策略的机制.
在移植前的HCC患者中探索新辅助免疫治疗的应用.

主要成果:

免疫疗法在肝移植之前有望改善HCC降级和瘤控制.
必须权衡潜在的益处与免疫相关毒性和移植后排斥的风险.
目标是扩大肝移植的获取范围,同时保持有利的移植前和移植后结果.

结论:

在肝移植之前,免疫疗法可能为精选的高风险HCC患者提供一种有价值的新辅助策略.
仔细考虑免疫风险对于在这种环境中成功整合免疫疗法至关重要.
需要进行进一步的研究,以优化免疫治疗的使用,并减轻移植前HCC患者群体的风险.

关键词:

在HCC中,HCC是HCC.下降阶段下降阶段免疫疗法免疫疗法肝移植肝移植肝移植这是一种新辅助剂.

更多相关视频

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma

Published on: September 30, 2021

Advances in Human Induced Pluripotent Stem Cell-Derived Chimeric Antigen Receptor-Expressing Natural Killer Cells

Advances in Human Induced Pluripotent Stem Cell-Derived Chimeric Antigen Receptor-Expressing Natural Killer Cells

Published on: February 14, 2025

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Tissue Transplantation

Tissue Transplantation

Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...